Page 5 - K. Development and regeneration
P. 5
A 3 0 0 B **
* ** 3 0 0 0
4 4 /p )
/p ) 4 s e G
ll lin e s e ra 4 G D 2 0 0 in g le ce ll lin e ra c ife 2 0 0 0
b le ce ife c to S u L e la tive to D 1 0 0 0
ta u L tive 1 0 0 (R
S la
e
(R
0
0 .3 μ g C trl + - -
0 6 .0 μ g B A C - + +
0 .3 μ g C trl + - - T o l2 tra n sp o sa se - - +
V e c to r 0 .6 6 7 μ g
6 .0 μ g B A C - + + Luciferase
T o l2 tra n sp o sa se
V e c to r 0 .6 6 7 μ g - - + Actin
C
0 .8
0 .3 μ g C trl
6 .0 μ g B A C
0 .6
B A C & T o l2
)
lls
e
μ C 0 .4
5
(E
0 .2
0 .0
3 6 9 1 2 1 5 1 8 2 1 2 4 2 7 3 0
D a y s
A B
3 0 0
1 0 0 ***
*
)
r 6 l
e 0 ** ve
e b m trl # *** e le trl) 2 0 0
BAC ll lin ce u n y C ll lin ce n tio C to
(200kb ~ 300kb) le g p o c to e tiv 5 0 le g crip tive la
Targeting in S e n e la e in S s n ra e (R 1 0 0
Vector G (R T ***
0 0
0 .3 μ g C trl + - - 0 .3 μ g C trl + - -
6 .0 μ g B A C - + + 6 .0 μ g B A C - + +
T o l2 tra n sp o sa se - - + T o l2 tra n sp o sa se - - +
Tol2 V e c to r 0 .6 6 7 μ g V e c to r 0 .6 6 7 μ g
CAM
Targeting
Vector
A B C
****
** * ****
6 0 0
1 5 0 0 ))
id ) .3 2 0 0
la sm trl(0
s e 4 0 0 trl(0 .3 )) s e
ra ** * s e ra C
c ife ra 1 0 0 0 ife to
u e la tive to P c ife **** c
L 2 0 0 u e la tiv e to C u L tiv e 1 0 0
(R L la e ****
(R 5 0 0 (R
0
C o n tro l 0 .3 μ g + - - 0
C o n tro l (μ g ) - - - - - -
B A C 6 .0 μ g - + +
B A C (μ g ) 8 8 8 8 8 8
T o l2 tra n s p o s a s e V e c to r - + - 0
C o n tro l (μ g ) 0 .3 - - - - - - B A C : T o l2 tra n s p o s a s e - 9 :0 .5 9 :1 9 :3 9 :6 9 :9
T o l2 tra n s p o s a s e m R N A - - + m R N A ra tio
B A C (μ g ) - 2 4 8 1 6 3 2 6 4
A B
3’ K CMV 5’ 5’ CMV K 3’
XmaI XhoI
3’ 5’
e1e2 e3 BAC targeting vector (BTV)
A Genome 3’arm 5’arm Genome
Reference
Conservation
5’ CMV K 3’
C BAC targeting cassette (BTC)
5’’ A SV40 N 3’’
C D e1e2 3’ K CMV 5’ e3
5’’ SV40 N A 3’’ CMV Tol2
BamHI XhoI
CAM targeting vector (CTV) N SV40 SV40 N A
E
5’’ SV40 N A 3’’
2
~
2
CAM targeting cassette (CTC) CMV SV40 N
Genome 5’arm 3’arm Genome
K A N 5’ 3’ 5’’ 3’’ Reference
Conservation
FRT SA SP Luciferase KanR AmpR NeoR Tol2 arm 5’ HR 3’ HR 5’’ HR 3’’ HR

